Summary
Two seriously injured trauma patients presenting with intense and progressive neutropenia are described. Bone marrow examination in both cases showed virtually absent granulopoiesis but normal erythropoiesis and megakaryopoiesis, allowing the diagnosis of acute agranulocytosis. Discontinuation of only one drug (dipyrone) with no further treatment was required for normalization of blood parameters. The association of dipyrone with neutropenia is still debatable. The recent medical literature on dipyrone generation of agranulocytosis is reviewed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barrett AJ, Weller E, Rozengurt N, Longhurst P, Humble JG (1976) Aminopyrine agranulocytosis: drug inhibition of granulocyte colonies in the presence of patients' serum. Br Med J 2: 850–851
Bottiger LE, Furhoff AK, Holmberg L (1979) Drug-induced blood dyscrasias. A ten-year material from the Swedish Adverse Drug Reaction Committee. Acta Med Scand 205: 457–461
Claas FHJ, Abbot PA, Witvliet MD, D'Amaro J, Barnes PM, Krupp P (1992) No direct clinical relevance of the human leucocyte antigen (HLA) system in clozapine-induced agranulocytosis. Drug Safety 7 [Suppl 1]: 3–6
Dale DC (1990) Neutropenia. In: Williams WJ, Beutler E, Erslew AJ, Lichtman MA (eds) Hematology. McGraw-Hill, New York, pp 807–816
Goudemand J, Plouvier J, Bauters F, Goudemand M (1976) Les agranulocytosis aigues induites par le pyramidon ou les phenothiazines. Semin Hop Paris 52: 1513–1520
Huguley CM jr (1964) Agranulocytosis induced by dipyrone, a hazardous antipyretic and analgesic. JAMA 189: 938–941
International Agranulocytosis and Aplastic Anemia Study (1986) Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special references to analgesics. JAMA 256: 1749–1757
Kracke RR, Parker FP (1935) Relationship of drug therapy to agranulocytosis. JAMA 105: 960–966
Laporte JR, Carne X (1987) Blood dyscrasias and the relative safety of non-narcotic analgesics. Lancet 1: 809
Moeschlin S, Wagner K (1952) Agranulocytosis due to the occurrence of leukocyte-agglutinins (pyramidon and cold agglutinins). Acta Haematol 8: 29–41
Pisciotta AV (1973) Immune and toxic mechanisms in druginduced agranulocytosis. Semin Hematol 10: 279–310
Stojanovic N, Rudivic R, Jovcic G, Mijovic A (1990) Druginduced agranulocytosis: bone marrow granulocytic progenitor cells. Biomed Pharmacother 44: 181–184
Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M (1992) Descriptive epidemiology of agranulocytosis. Arch Intern Med 152: 1475–1480
Vlahov V, Bacracheva N (1989) Agranulocytosis and dipyrone. Lancet 2: 1215
Young GAR, Vincent PC (1980) Drug-induced agranulocytosis. Clin Haematol 9: 483–504
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sabbaga, J., Osawa, C., Pahl, F.H. et al. Acute agranulocytosis after prolonged high-dose usage of intravenous dipyrone — a different mechanism of dipyrone toxicity?. Ann Hematol 66, 153–155 (1993). https://doi.org/10.1007/BF01697627
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01697627